Session detail

Back to the session list

Session type
Friday, April 26th 2019
Session time
14h00 - 15h30
Best posters session
Ralf GUTZMER (Germany)
Gaëlle QUEREUX (France)
Henri MONTAUDIE (France)
Emmanuella GUENOVA (Switzerland)
14h00 - 14h05
P003 - Usefulness of the “two-step method” of digital follow-up in early stage melanoma detection in at high risk french patients - a retrospective study
Giulia Gasparini, Nika Madjlessi, Julie Delyon, Luca Carmisciano, Nesrine Brahimi, Martine Bagot, Nicole Basset-Seguin, Maxime Battistella, Céleste Lebbé, Florian Herms, Barouyr Baroudjian (Italy)
14h05 - 14h10
P004 - Association between breslow thickness and dermoscopic findings in melanoma
Maria Victoria Rodriguez Kowalczuk, Maria Manuela Martinez Piva, Aldana Vacas, Florencia Gallo, Rosa Marigle Rodrigues Vasconcelos, Maite Lisa Eliceche, Alicia Maria Kowalczuk, Luis Mazzuoccolo (Argentina)
14h10 - 14h15
P018 - A study on confidence in classification of skin lesions by deep neural networks
Pieter Van Molle, Tim Verbelen, Bert Vankeirsbilck, Sofie Mylle, Evelien Verhaeghe, Lieve Brochez, Jonas De Vylder, Bart Diricx, Pieter Simoens, Bart Dhoedt (Belgium)
14h15 - 14h20
P001 - Genomic aberrations may predict positive sentinel lymph node biopsy in melanoma of young adults
Sophia Ma, Karina Vivar, Vernon Sondak, Jane Messina (United States)
14h20 - 14h25
P002 - Stromal gene expression predicts sentinel lymph node metastasis of primary cutaneous melanoma
Sindhuja Sominidi-Damodaran, Suzette Arias Mejias, Mark R Pittelkow, Julia S Lehman, Tina J Hieken, Martin H. van Vliet, Jvalini Dwarkasing, Domenico Bellomo, Alexander Meves (United States)
14h25 - 14h30
P006 - Development and validation of a nomogram to assess sentinel node biopsy positivity in melanoma patients
Eduardo Bertolli, Vinicius Fernando Calsavara, Mariana Petaccia de Macedo, Clovis Antonio Lopes Pinto, João Pedreira Duprat Neto (Brazil)
14h30 - 14h35
P005 - Whole-body MRI including diffusion weighted imaging for the surveillance of melanoma patients at high risk for recurrence
Yanina Jeanne Leona Jansen, Willekens inneke, Carola Brussaard, Bart Neyns (Belgium)
14h35 - 14h40
P008 - Clinical significance of braf/nras concurrent mutations in a clinic-based metastatic melanoma cohort
Laura Del Regno, Baptiste Louveau, Barouyr Baroudjian, Aurelie Sadoux, Maxime Battistella, Julie Delyon, Nicole Basset Seguin, Celeste Lebbe, Samia Mourah, Fanelie Jouenne (France)
14h40 - 14h45
P010 - Molecular genetic testing of ocular melanoma (uveal and conjunctival melanoma)
Valeriya Nazarova, Kristina Orlova, Mazurenko Natalia, Igor Utyashev, Lev Demidov (Russian Federation)
14h45 - 14h50
P007 - Epidemiological study of adjuvant treatments from the french national melanoma database RIC-MEL
Emilie Varey, Stéphane Dalle, Thierry Lesimple, Henri Montaudié, Bernard Guillot, Laurent Mortier, Marie-Thérèse Leccia, François Skowron, Philippe Celerier, Nicolas Meyer, Amir Khammari, Céleste Lebbé, Brigitte Dreno (France)
14h50 - 14h55
P009 - MIR-193a as therapeutic agent in cutaneous melanoma
Sara Carpi, Beatrice Polini, Antonella Romanini, Paola Nieri (Italy)
14h55 - 15h00
P011 - Response to chemotherapy after immunotherapy in 19 advanced melanoma patients
Mélanie Saint-Jean, Clémentine Fronteau, Lucie Peuvrel *, Eugénie Clapeau, Anthony Sourisseau, Justine Daguzé, Louise Muguet, Amir Khammari, Emilie Varey, Gaëlle Quéreux, Brigitte Dréno (France)
15h00 - 15h05
P015 - Impact of radiotherapy administered simultaneously with systemic treatment in patients with melanoma brain metastases
Pauline Tetu, Clara Allayous, Bastien Oriano, Stéphane Dalle, Laurent Mortier, Marie-Therese Leccia, Bernard Guillot, Sophie Dalac, Caroline Dutriaux, Jean-Philippe Lacour, Philippe Saiag, Florence Brunet-Possenti, Julie De Quatrebarbes, Pierre-Emmanuel Stoebner, Delphine Legoupil, Marie Beylot-Barry, Thierry Lesimple, François Aubin, Brigitte Dreno, Sameh Mohamed, Alice Ballon, Raphaël Porcher, Céleste Lebbé (France)
15h05 - 15h10
P012 - The importance of pharmacists for dabrafenib and trametinib use in real-life: analysis of data from pharmaceutical consultations since 2016
Claire Davoine, François Cartier, Anne Toulemonde-Deldicque, Pauline Laly, Céleste Lebbé, Barouyr Baroudjian, Julie Delyon, Isabelle Madelain (France)
15h10 - 15h15
P013 - Severe gastrointestinal toxicity of MEK inhibitors: a 5-year monocentric experience
Barouyr Baroudjian, Nadim Mourad, Nelson Lourenco, Julie Delyon, Pirayeh Eftekhari, Philippe Bertheau, Clara Allayous, Cécile Pagès, Mathieu Allez, Céleste Lebbé (France)
15h15 - 15h20
P014 - Immune-related hepatitis: clinical aspect and proposed management
Marie-Léa Gauci, Barouyr Baroudjian, Ulysse Bédérède, Charlotte Zéboulon, Julie Delyon, Clara Allayous, Martine Bagot, Isabelle Madelaine, Matthieu Resche-Rigon, Nicolas Poté, Mohamed Bouattour, Olivier Roux, Céleste Lebbé (France)
15h20 - 15h25
P016 - Improving patient experience of immunotherapy treatment for melanoma: the leeds nurse-led immunotherapy telephone clinic
Maria Marples, Helen Jackson, Helen Nicholson, Beverley Ryder, Karen Ingham, Jane Hook (United Kingdom)

By continuing to browse this website, you accept cookies which are used to offer a personalized experience on our website, generate statistics and realize advertising or social network tracking. Find out more about our Privacy & Cookie policy and how to manage them on your browser. You can change your cookie settings at any time.

Ok Read more